Similarly, MITF was lower in tumours with chromosome 8q gain/amplification compared to UMs with normal 8q status (p = 0.02), as well as in tumours with negative BAP1 IHC staining compared to BAP1-positive tumours (p = 0.002). This evidence concerns the gene MITF and neoplasm.